These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 188401)

  • 21. 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases.
    Johannsson B; Roos BE
    Eur Neurol; 1974; 11(1):37-45. PubMed ID: 4363875
    [No Abstract]   [Full Text] [Related]  

  • 22. Elevated levels of cerebrospinal fluid guanosine 3',5'-cyclic monophosphate (C-GMP) in systemic lupus erythematosus.
    Kassan SS; Kagen LJ
    Am J Med; 1978 May; 64(5):732-41. PubMed ID: 206141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cerebrospinal fluid cAMP and cGMP in various peripheral and central nervous system diseases. Preliminary report].
    Jurkowski A; Czernicki J; Maciejek Z
    Neurol Neurochir Pol; 1981; 15(3):277-82. PubMed ID: 6273761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Albumin and IGG in the CSF as demonstration of blood-brain barrier damage and of immune response within the CNS (author's transl)].
    Cognazzo A; Gerbino Promis PC; Grasso E
    Riv Patol Nerv Ment; 1981; 101(3):151-64. PubMed ID: 7256113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF levels of cyclic nucleotides and adrenergic metabolites in malignant gliomas.
    Gerosa MA; Olivi A; Longatti PL; Teolato S; Carteri A
    Surg Neurol; 1980 May; 13(5):359-62. PubMed ID: 6155709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid carcinoembryonic antigen in patients with metastatic and nonmetastatic neurological diseases.
    Twijnstra A; Nooyen WJ; van Zanten AP; Hart AA; Ongerboer de Visser BW
    Arch Neurol; 1986 Mar; 43(3):269-72. PubMed ID: 3947276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels.
    Gómez-Vallejo V; Ugarte A; García-Barroso C; Cuadrado-Tejedor M; Szczupak B; Dopeso-Reyes IG; Lanciego JL; García-Osta A; Llop J; Oyarzabal J; Franco R
    J Neurochem; 2016 Jan; 136(2):403-15. PubMed ID: 26641206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty acid changes of cerebrospinal fluid in neurological disorders as an index of changes in the blood-brain barrier.
    Pazzagli A; Arnetoli G; Pepeu I; Amaducci LA
    Neurology; 1970 Aug; 20(8):783-6. PubMed ID: 5465848
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased cerebrospinal fluid cAMP levels in Alzheimer's disease.
    Martínez M; Fernández E; Frank A; Guaza C; de la Fuente M; Hernanz A
    Brain Res; 1999 Nov; 846(2):265-7. PubMed ID: 10556645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective D1 agonism but not D2 antagonism is reflected in cAMP and cGMP levels in rat CSF.
    Torremans A; Van Hemelrijck A; Straetemans R; Vanhoof G; Van Den Kieboom G; Drinkenburg WH
    Brain Res Bull; 2010 Apr; 81(6):549-51. PubMed ID: 20015466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysozyme activity in cerebrospinal fluid.
    Reitamo S; Klockars M
    Acta Med Scand; 1976; 199(4):321-5. PubMed ID: 1266668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in the patients with epilepsy (author's transl)].
    Nagao T; Fujimoto A; Ohshimo T; Yamamoto M; Kugoh T; Akiyama K; Otsuki S
    No To Shinkei; 1979 Dec; 31(12):1225-31. PubMed ID: 93481
    [No Abstract]   [Full Text] [Related]  

  • 33. [Levels of cyclic adenosine-3',5'-monophosphate (cyclic AMP) and cyclic guanosine-3',5'-monophosphate (cyclic GMP) in human lumbar and ventricular cerebrospinal fluid. Changes in coma].
    Livrea P; di Reda N; de Blasi A; Pierangeli E; Fiore T; Bertolino A
    Acta Neurol Quad (Napoli); 1978; 37():9-17. PubMed ID: 229691
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased CSF levels of somatostatin in patients with brain tumours and intracranial hypertension.
    Stepień H; Stawowy A; Cieślak D; Brzeziński J; Pawlikowski M
    Horm Metab Res; 1986 Aug; 18(8):555-7. PubMed ID: 2875924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic nucleotides and cerebrovascular tone in newborn pigs.
    Parfenova H; Shibata M; Zuckerman S; Mirro R; Leffler CW
    Am J Physiol; 1993 Dec; 265(6 Pt 2):H1972-82. PubMed ID: 8285236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytological examination of the cerebrospinal fluid.
    Iivanainen M; Taskinen E
    Ann Clin Res; 1973 Apr; 5(2):80-6. PubMed ID: 4748755
    [No Abstract]   [Full Text] [Related]  

  • 37. Aspects of CSF cytology in some neurological diseases.
    Appel E
    Rev Roum Neurol; 1973; 10(4):371-83. PubMed ID: 4767892
    [No Abstract]   [Full Text] [Related]  

  • 38. Absolute or relative values in csf electrophoresis? An evaluation of the gamma-globulins in multiple sclerosis and other neurological diseases.
    Ackermann HP; Rieder HP; Wüthrich R
    Eur Neurol; 1975; 13(2):131-43. PubMed ID: 49269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patients.
    Gattaz WF; Cramer H; Beckmann H
    Biol Psychiatry; 1984 Aug; 19(8):1229-35. PubMed ID: 6149769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases.
    Sundquist J; Forsling ML; Olsson JE; Akerlund M
    J Neurol Neurosurg Psychiatry; 1983 Jan; 46(1):14-7. PubMed ID: 6842195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.